TAA
LLY icon

TB Alternative Assets’s Eli Lilly LLY Stock Holding History

TB Alternative Assets’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-590
Closed -$460K – 54
2025
Q2 		$460K Hold
590
– – 0.09% 37
2025
Q1 		$487K Buy
+590
New +$491K 0.11% 42

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

TB Alternative Assets's LLY Position: Q3 2025 in Review

TB Alternative Assets sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 590 shares — an estimated $460K sold.

TB Alternative Assets first reported a position in LLY in Q1 2025 and held it in 2 quarters. The position peaked at $487K in Q1 2025. 3,903 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • TB Alternative Assets reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • TB Alternative Assets sold 590 Eli Lilly shares in Q3 2025, an estimated $460K.
  • TB Alternative Assets first reported a position in Eli Lilly in Q1 2025 and held it in 2 quarters.
  • TB Alternative Assets's Eli Lilly position peaked at $487K in Q1 2025.
  • 3,903 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on TB Alternative Assets's 13F filing for Q3 2025, filed 17 Oct 2025.